If you find this podcast useful please give it a rating and review on iTunes by clicking here
Do you want to get instant company alerts to the front screen of your smartphone? Download the Vox Markets app here: www.VoxMarkets.co.uk/app
On today's Vox Markets Podcast: Shield Therapeutics (STX) and Malcy on (INFA) (TRIN) (JOG) (HUR) (GENL) (FOG) (VOG)
Carl Sterritt, Chief Executive Officer and Founder of Shield Therapeutics (STX) talks about the commercial progress of their lead product Feraccru®.
Shield is a commercial stage, pharmaceutical company delivering innovative specialty pharmaceuticals to address patients' unmet medical needs. Our clear purpose is to help our patients become people again, by enabling them to enjoy the things that make the difference in their everyday lives. The Group has a marketed product, Feraccru®, for the treatment of iron deficiency in adult patients with or without anaemia. Feraccru® has exclusive IP rights until the mid-2030's. For more information please visit www.shieldtherapeutics.com.
Oil & Gas Sector specialist Malcy talks about the following stocks:
Infrastrata (INFA)
Trinity Exploration & Production (TRIN)
Jersey Oil & Gas (JOG)
Hurricane Energy (HUR)
Genel Energy (GENL)
Falcon Oil & Gas (FOG)
Victoria Oil & Gas (VOG)
(Interview starts at 13 minutes 23 seconds)